Literature DB >> 1690568

Protein zero of peripheral nerve myelin: biosynthesis, membrane insertion, and evidence for homotypic interaction.

D D'Urso1, P J Brophy, S M Staugaitis, C S Gillespie, A B Frey, J G Stempak, D R Colman.   

Abstract

Protein zero (P0), an integral membrane glycoprotein synthesized by Schwann cells, is the major glycoprotein of peripheral nerve myelin. The predicted disposition of P0 with respect to the membrane bilayer postulates the existence of extracellular and intracellular domains, that mediate compaction of the myelin lamellae. We used in vitro translations programmed with sciatic nerve mRNA and cells transfected with a P0 cDNA construct to study the biosynthesis and topology of P0 in the bilayer. The behavior of P0 at the cell surface, when expressed under physiological conditions, was also examined. We have verified the topological predictions of an earlier model, derived from analysis of a P0 cDNA, and provide evidence that the extracellular domain of P0 mediates homotypically cell-cell interactions in the transfectants.

Mesh:

Substances:

Year:  1990        PMID: 1690568     DOI: 10.1016/0896-6273(90)90057-m

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  55 in total

Review 1.  Neuroactive steroids: A therapeutic approach to maintain peripheral nerve integrity during neurodegenerative events.

Authors:  Emanuela Leonelli; Marinella Ballabio; Antonio Consoli; Ilaria Roglio; Valerio Magnaghi; Roberto C Melcangi
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

Review 2.  Myelin P0: new knowledge and new roles.

Authors:  Joseph Eichberg
Journal:  Neurochem Res       Date:  2002-11       Impact factor: 3.996

3.  Glycoproteins and lectins in cell adhesion and cell recognition processes.

Authors:  J P Zanetta; S Kuchler; S Lehmann; A Badache; S Maschke; D Thomas; P Dufourcq; G Vincendon
Journal:  Histochem J       Date:  1992-11

Review 4.  Features and functions of oligodendrocytes and myelin proteins of lower vertebrate species.

Authors:  Gunnar Jeserich; Katrin Klempahn; Melanie Pfeiffer
Journal:  J Mol Neurosci       Date:  2008-02-26       Impact factor: 3.444

5.  Proteolipid protein cannot replace P0 protein as the major structural protein of peripheral nervous system myelin.

Authors:  Xinghua Yin; Sumiko Kiryu-Seo; Grahame J Kidd; M Laura Feltri; Lawrence Wrabetz; Bruce D Trapp
Journal:  Glia       Date:  2014-07-28       Impact factor: 7.452

6.  Enhanced axonal neuregulin-1 type-III signaling ameliorates neurophysiology and hypomyelination in a Charcot-Marie-Tooth type 1B mouse model.

Authors:  Cristina Scapin; Cinzia Ferri; Emanuela Pettinato; Desiree Zambroni; Francesca Bianchi; Ubaldo Del Carro; Sophie Belin; Donatella Caruso; Nico Mitro; Marta Pellegatta; Carla Taveggia; Markus H Schwab; Klaus-Armin Nave; M Laura Feltri; Lawrence Wrabetz; Maurizio D'Antonio
Journal:  Hum Mol Genet       Date:  2019-03-15       Impact factor: 6.150

Review 7.  Expression and biological functions of sulfoglucuronyl glycolipids (SGGLs) in the nervous system--a review.

Authors:  F B Jungalwala
Journal:  Neurochem Res       Date:  1994-08       Impact factor: 3.996

8.  Charcot-Marie-Tooth disease: a novel Tyr145Ser mutation in the myelin protein zero (MPZ, P0) gene causes different phenotypes in homozygous and heterozygous carriers within one family.

Authors:  Alejandro Leal; Corinna Berghoff; Martin Berghoff; Gerardo Del Valle; Carlos Contreras; Olga Montoya; Erick Hernández; Ramiro Barrantes; Ursula Schlötzer-Schrehardt; Bernhard Neundörfer; André Reis; Bernd Rautenstrauss; Dieter Heuss
Journal:  Neurogenetics       Date:  2003-07-05       Impact factor: 2.660

9.  Two novel missense mutations in the myelin protein zero gene causes Charcot-Marie-Tooth type 2 and Déjérine-Sottas syndrome.

Authors:  Geir J Braathen; Jette C Sand; Michael B Russell
Journal:  BMC Res Notes       Date:  2010-04-12

10.  Myelin/oligodendrocyte glycoprotein is a member of a subset of the immunoglobulin superfamily encoded within the major histocompatibility complex.

Authors:  D Pham-Dinh; M G Mattei; J L Nussbaum; G Roussel; P Pontarotti; N Roeckel; I H Mather; K Artzt; K F Lindahl; A Dautigny
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.